BioNTech (Germany)

BioNTech (Germany)

BioNTech SE is a global biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioNTech (Germany), Germany, covering academic research published from 2003 to 2024. Read More.


Open Access Percentage

72%


Total
Publications

572


Total Open
Publications

414


Total
Citations

33K


Open Access
Percentage

72%


Total
Publications

572


Total Open
Publications

414


Total
Citations

33K

Wikipedia

Website

download

Breakdown

22% 38% 13% 27%

Publisher Open

22%

Both

38%

Other Platform Open

13%

Closed

27%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090Total Publications
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

39%OA Journal

OA Journal 39%

133

Hybrid 43%

145

No Guarantees 18%

62

Other Platform Open

Domain 73%

211

Preprint 24%

69

Institution 13%

39

Other Internet 13%

38

Public 8%

24

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
212
Europe PMC
Domain
68
DOI
Other Internet
45
bioRxiv
Preprint
38
Figshare
Public
25
Research Square
Preprint
12
Semantic Scholar
Public
10
medRxiv
Preprint
9
University of Southampton - ePrints Soton
Institution
8
University of Zurich - Zurich Open Repository and Archive
Institution
6
1 / 5

Data updated 13 February 2025

Share

Share

Share